
Enhanced R&D Intensive Support
UK R&D tax relief for loss-making, research-intensive small firms.
Enhanced R&D Intensive Support is the separate tax-relief route for eligible loss-making, research-intensive small companies. It applies to accounting periods beginning on or after 1 April 2024.
Last refreshed: 22 October 2026 · Appears in 1 active topic
Timeline for Enhanced R&D Intensive Support
HMRC: R&D tax relief rises as claims fall 17%
UK Startups and InnovationBackground
Enhanced R&D Intensive Support, usually called ERIS, is a UK research tax-relief scheme for eligible loss-making small and medium-sized companies. It combines an additional deduction for qualifying research costs with a payable credit against surrenderable losses. It preserves a distinct route for research-intensive businesses within the wider Reform of company research relief. [HMRC scheme history](https://www.GOV.UK/government/statistics/corporate-tax-research-and-development-tax-credit/research-and-development-tax-credits-statistics-september-2026)
Eligibility depends on a company making a tax trading loss before the extra deduction and meeting the research-intensity condition. Connected-company expenditure enters that assessment. The scheme has the same qualifying-cost rules as merged RDEC but calculates relief differently. An eligible business can choose merged RDEC instead, without claiming both schemes on the same expenditure. [HMRC guidance](https://www.GOV.UK/guidance/research-and-development-rd-tax-relief-the-merged-scheme-and-enhanced-rd-intensive-support)
What does ERIS stand for?
Who is ERIS intended to support?
Can a company claim ERIS and merged RDEC on the same spending?
Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Updated 22 October 2026. Editorial standards.